PT Mobile Logo

Search form


E. Fuller Torrey, MD

E. Fuller Torrey, MD

Dr Torrey is a research psychiatrist who specializes in schizophrenia and bipolar disorder. He is founder of the Treatment Advocacy Center and Associate Director of the Stanley Medical Research Institute, which supports research on schizophrenia and bipolar disorders, and he is Professor of Psychiatry at the Uniformed Services University of the Health Sciences in Bethesda, Md. He is the author of American Psychosis: How the Federal Government Destroyed the Mental Illness Treatment System.

Posts by Author

© Sergey Lavrentev /shutterstock.com

How to decrease recidivism for individuals with serious mental illnesses who are released from jails or prisons or discharged from hospitals? Here are several effective mechanisms.

After lounging on the doorstep of respectability for the past decade, assisted outpatient treatment is here to stay. But some still balk at the notion.

Image Point fr / shutterstock.com

Here: common misconceptions about assisted outpatient treatment--and how this tool can help selected mentally ill patients who are most difficult to treat.

Individuals with serious mental illness are responsible for more than 7% of the nation’s homicides. What can be done to reduce this deadly phenomenon?


Reasons for the overall low rate of clozapine use brings to light questionable decisions on the part of policymakers

The current shortage of psychiatric beds in the US is a major problem. Patients are discharged prematurely and often have to be readmitted or end up homeless or incarcerated.

A report on Medicaid and Medicare fraud, excessive waste, and frivolous expenditures—all at the expense of those who suffer from psychiatric illness.

The funding of mental illness services in the US is more thought-disordered than any of the thought-disordered patients it is meant to serve.

Clearly, some with schizophrenia fare better without antipsychotic drugs. But not all. Many individuals with schizophrenia are better off taking antipsychotic drugs for long-term.

The idea that schizophrenia and bipolar disorder might be caused by infection is not new. New research on infectious agents in patients with schizophrenia and bipolar disorder has implications for psychiatric clinicians.


By clicking Accept, you agree to become a member of the UBM Medica Community.